|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.670 USD | +11.33% |
|
-.--% | +221.15% |
| 06-01 | Revium Rx. Announces CFO Changes, Effective May 27, 2026 | CI |
| 05-15 | Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Non-Durable Goods Distribution | ||||
Net Income | -1.21M | -683K | -3.5M | -13.45M |
D&A | 2K | 2K | 4K | 6K |
Operating Income | -1.19M | -680K | -3.57M | -13.15M |
EBT | -1.21M | -683K | -3.5M | -13.09M |
CAPEX | -2K | -1K | -3K | -7K |
Income Tax Expense | - | - | - | 358K |
Interest Expense | -22K | -3K | -2K | - |
Total Assets | 460K | 5.63M | 20.28M | 8.3M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Operating Income | -1.19M | -680K | -3.57M | -13.15M |
Net Income | -1.21M | -683K | -3.5M | -13.45M |
EBT | -1.21M | -683K | -3.5M | -13.09M |
CAPEX | -2K | -1K | -3K | -7K |
D&A | 2K | 2K | 4K | 6K |
Income Tax Expense | - | - | - | 358K |
Interest Expense | -22K | -3K | -2K | - |
Total Assets | 460K | 5.63M | 20.28M | 8.3M |
- Stock Market
- Stocks
- RVRC Stock
- Financials Revium Rx.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
